Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 24 Nausea 20 Breast Neoplasms 8 Neoplasms 7 Multiple Myeloma 5 Lymphoma 5 Ovarian Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myeloid, Acute 4 Myeloproliferative Disorders 3 Carcinoma, Non-Small-Cell Lung 3 Testicular Neoplasms 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Neutrophilic, Chronic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

fexofenadine 1 Prednisone 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × ITCH × Aprepitant × Clear all

NCT01683552 2012-09-12

AprepIt

Campus Bio-Medico University

Phase 2 Completed

ITCH

Data powered by HemOnc (CC BY 4.0) Colophon ⚡